| Association between high risk of obstructive sleep apnea and inflammatory markers in a population sample of young and middle-aged adults in the Miami Heart Study AA Khosla, K Nasir, A Saxena, E Aneni, SS Ali, J Valero-Elizondo, ... Journal of Clinical Sleep Medicine, jcsm. 11274, 2024 | | 2024 |
| A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR) MS Ahluwalia, A Ozair, M Rudek, X Ye, M Holdhoff, FS Lieberman, ... Cell Reports Medicine, 2024 | | 2024 |
| End-of-life care preferences in patients with gallbladder cancer: Shifting patterns and disparities over two decades. K Jatwani, M Sukaina, AA Khosla, N Batra, R Mishra, MA Ganiyani, ... Journal of Clinical Oncology 42 (16_suppl), 12036-12036, 2024 | | 2024 |
| Trends in hospice utilization and place of death preferences in multiple myeloma-related deaths from 2003 to 2020: Analysis of CDC Wonder database. MS Faisal, M Sukaina, R Mishra, AA Khosla, N Batra, MS Kumar, N Soror, ... Journal of Clinical Oncology 42 (16_suppl), e24039-e24039, 2024 | | 2024 |
| YouTube as a reliable source of information on antibody drug conjugates: A qualitative analysis. SH Karass, R Chahal, N Singh, N Kutheala, M Sukaina, SP Kaur, ... Journal of Clinical Oncology 42 (16_suppl), 9050-9050, 2024 | | 2024 |
| Next-generation sequencing in patients with lung cancer undergoing immunotherapy: Retrospective analysis. A Batra, AA Khosla, D Alejos, J Kim, S Searles, A Chitkara, K Jatwani, ... Journal of Clinical Oncology 42 (16_suppl), e15071-e15071, 2024 | | 2024 |
| Implications of HPV infection on survival outcomes in patients with penile squamous cell carcinoma: Insights from a nationwide study. R Garje, MA Ganiyani, AA Khosla, S Ahmad, V Podder, SS Bellur, ... Journal of Clinical Oncology 42 (16_suppl), 5045-5045, 2024 | | 2024 |
| Clustering analysis for predicting racial disparities in genitourinary cancer–related financial burden. Y Zhang, AA Khosla, S Chhabra, N Batra, MA Ganiyani, A Goyal, ... Journal of Clinical Oncology 42 (16_suppl), e13612-e13612, 2024 | | 2024 |
| Socioeconomic disparities in survival outcomes of patients with NSCLC with brain metastases: A real-world analysis. SS Bellur, S Ahmad, V Bhat, MA Ganiyani, A Ozair, D Jayram, AA Khosla, ... Journal of Clinical Oncology 42 (16_suppl), 8569-8569, 2024 | | 2024 |
| Impact of treatment approaches in patients with advance penile cancer: An analysis from a nationwide study. MA Ganiyani, AA Khosla, S Ahmad, K Jatwani, M Rubens, M Roy, ... Journal of Clinical Oncology 42 (16_suppl), e17024-e17024, 2024 | | 2024 |
| Impact of race and ethnicity on financial toxicity in patients with genitourinary cancers. AA Khosla, N Batra, MA Ganiyani, SS Bellur, A Ozair, K Jatwani, R Singh, ... Journal of Clinical Oncology 42 (16_suppl), 11077-11077, 2024 | | 2024 |
| Association between congenital heart disease and cancer: A meta-analysis of 30 million patients. N Batra, V Jaiswal, AA Khosla, N Deb, A Vadhera, M Hanif, A Sawhney, ... Journal of Clinical Oncology 42 (16_suppl), 10568-10568, 2024 | | 2024 |
| Socioeconomic disparities in survival outcomes of patients with SCLC with brain metastases: A nationwide analysis. SS Bellur, D Jayram, S Ahmad, V Bhat, A Ozair, MA Ganiyani, AA Khosla, ... Journal of Clinical Oncology 42 (16_suppl), e20133-e20133, 2024 | | 2024 |
| Epidemiology, symptomatology, diagnosis and clinical implications of cystic tumors of atrioventricular node (CTAVN): A systematic review. V Jaiswal, N Batra, AA Khosla, Y Mashkoor, A Vadhera, AB Shrestha, ... Journal of Clinical Oncology 42 (16_suppl), e23561-e23561, 2024 | | 2024 |
| Cancer screening in sexual and gender minority populations: A systematic review and meta-analysis. AA Khosla, N Batra, K Jatwani, R Singh, M Rubens, V Ramamoorthy, ... Journal of Clinical Oncology 42 (16_suppl), 10540-10540, 2024 | | 2024 |
| Fibrolamellar hepatocellular carcinoma (FL-HCC) epidemiology, survival characteristics, and outcomes: Surveillance, epidemiology, and end results database (SEER) study. Z Alnabulsi, N Batra, AA Khosla, AM Attia, M Kiryakoza, N Deb, ... Journal of Clinical Oncology 42 (16_suppl), e16213-e16213, 2024 | | 2024 |
| A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE). MS Ahluwalia, MJ Ciesielski, DA Reardon, NA Butowski, R Aiken, ... Journal of Clinical Oncology 42 (16_suppl), TPS2099-TPS2099, 2024 | | 2024 |
| Impact of body mass index (BMI) on survival outcomes in patients with cancer treated with immune checkpoint inhibitors (ICPI): A systematic review and meta analysis. R Mishra, M Sukaina, N Batra, MS Kumar, KS Walia, R Chahal, AA Khosla, ... Journal of Clinical Oncology 42 (16_suppl), 2624-2624, 2024 | | 2024 |
| Retrospective analysis on association of body mass index and immune checkpoint inhibitor response. A Batra, A Vyas, AA Khosla, A Chitkara, D Alejos, X Xu, K Jatwani, ... Journal of Clinical Oncology 42 (16_suppl), e14536-e14536, 2024 | | 2024 |
| Ethnic disparities in biomarker testing of patients with metastatic NSCLC in the United States: A real-world analysis. D Jayram, SS Bellur, A Ozair, S Ahmad, MA Ganiyani, AA Khosla, ... Journal of Clinical Oncology 42 (16_suppl), e20617-e20617, 2024 | | 2024 |
Manmeet Ahluwalia, MD, MBA, FASCOChief Scientific Officer, Chief of Medical Oncology, and Deputy Director, Miami Cancer Institute在 baptisthealth.net 的电子邮件经过验证
